Screening and identification of serum proteomic biomarkers for gastric adenocarcinoma

Experimental and Therapeutic Medicine

Volumn 3, Issue 6, 2012, Pages 1005-1009

  Liu, Chibo ^a   Pan, Chunqin ^a   Liang, Yong ^a  

^a TAIZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

Apolipoprotein A II; Apolipoprotein C I; Biomarker; Fibrinogen a chain; Gastric cancer; Proteome; Serum; Surface enhanced laser desorption ionization time of flight mass spectrometry

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN C1; BIOLOGICAL MARKER; FIBRINOGEN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; MOLECULAR WEIGHT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEOMICS; SCREENING; SENSITIVITY AND SPECIFICITY; STOMACH ADENOCARCINOMA; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EID: 84859466197     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.515     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
3. Tseng CW, Yang JC, Chen CN, et al: Identification of 14-3-3beta in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker. Proteomics 11: 2423-2439, 2011.
4. Kobayashi Y, Niwa Y, Tajika M, et al: Serum tumor antigen REG4 as a useful diagnostic biomarker in gastric cancer. Hepatogastroenterology 57: 1631-1634, 2010.
5. Yang S and Chung HC: Novel biomarker candidates for gastric cancer. Oncol Rep 19: 675-680, 2008.
6. Chan DC, Chen CJ, Chu HC, et al: Evaluation of serum amyloid A as a biomarker for gastric cancer. Ann Surg Oncol 14: 84-93, 2007.
7. Poon TC: Opportunities and limitations of SELDI-TOF-MS in biomedical research: practical advices. Expert Rev Proteomics4: 51-65, 2007.
8. Cho WC: Research progress in SELDI-TOF MS and its clinical applications. Sheng Wu Gong Cheng Xue Bao 22: 871-876, 2006 (In Chinese).
9. Clarke CH, Buckley JA and Fung ET: SELDI-TOF-MS proteomics of breast cancer. Clin Chem Lab Med 43: 1314-1320, 2005.
10. Liu C: The application of SELDI-TOF-MS in clinical diagnosis of cancers. J Biomed Biotechnol 2011: 245821, 2011.
11. Caffrey RE: A review of experimental design best practices for proteomics based biomarker discovery: focus on SELDI-TOF. Methods Mol Biol 641: 167-183, 2010.
12. Kristina G, Radomir P, Eva B, et al: When one chip is not enough: augmenting the validity of SELDI-TOF proteomic profiles of clinical specimens. Lab Chip 9: 1014-1017, 2009.
13. Liu W, Gao X, Cai Q, et al: Identification of novel serum biomarkers for gastric cancer by magnetic bead. Front Biosci (Elite Ed) 2: 961-971, 2010.
14. Huang Q, Chen W, Wang L, Lin W, Lin J and Lin X: Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology. J Cancer Res Clin Oncol 134: 1219-1227, 2008.
15. Umemura H, Togawa A, Sogawa K, et al: Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis. J Gastroenterol 46: 577-585, 2011.
16. Wang J, Yu JC, Kang WM and Ma ZQ: Treatment strategy for early gastric cancer. Surg Oncol: Jan 21, 2011 (Epub ahead of print).
17. Saka M, Morita S, Fukagawa T and Katai H: Present and future status of gastric cancer surgery. Jpn J Clin Oncol 41: 307-313, 2011.
18. Cho WC: Proteomics technologies and challenges. Genomics Proteomics Bioinformatics 5: 77-85, 2007.
19. Cho WC: Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 6: 25, 2007.
20. Lei L, Wang XJ, Zheng ZG, et al: Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS. Anat Rec (Hoboken) 294: 941-944, 2011.
21. Felix K, Fakelman F, Hartmann D, et al: Identification of serum proteins involved in pancreatic cancer cachexia. Life Sci 88: 218-225, 2011.
22. Liu L, Liu J, Wang Y, et al: A combined biomarker pattern improves the discrimination of lung cancer. Biomarkers 16: 20-30, 2011.
23. Hogdall E, Fung ET, Christensen IJ, et al: Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients. Proteomics Clin Appl 4: 940-952, 2010.
24. Gemoll T, Roblick UJ, Auer G, Jornvall H and Habermann JK: SELDI-TOF serum proteomics and colorectal cancer: a current overview. Arch Physiol Biochem 116: 188-196, 2010.
25. Konstantopoulos K and Thomas SN: Cancer cells in transit: the vascular interactions of tumor cells. Annu Rev Biomed Eng 11: 177-202, 2009.
26. Costantini V and Zacharski LR: The role of fibrin in tumor metastasis. Cancer Metastasis Rev 11: 283-290, 1992.
27. Vanhollebeke B and Pays E: The function of apolipoproteinsL. Cell Mol Life Sci 63: 1937-1944, 2006.
28. Ashe PC and Berry MD: Apoptotic signaling cascades. Prog Neuropsychopharmacol Biol Psychiatry 27: 199-214, 2003.
29. Engwegen JY, Helgason HH, Cats A, et al: Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. World J Gastroenterol 12: 1536-1544, 2006.
30. Fan Y, Wang J, Yang Y, et al: Detection and identification of potential biomarkers of breast cancer. J Cancer Res Clin Oncol 136: 1243-1254, 2010.